Loading clinical trials...
Loading clinical trials...
This study will be conducted to assess the role of end-tidal carbon dioxide (PETCO2) monitoring to predict the fluid volume responsiveness in correlation with stroke volume variation detected by electrical cardiometry in patients with hemodynamic instability.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Tanta University Hospitals
Tanta, ElGharbiaa, Egypt
Start Date
June 1, 2019
Primary Completion Date
January 1, 2021
Completion Date
January 31, 2021
Last Updated
February 21, 2021
60
ACTUAL participants
end tidal carbon dioxide by capnography
DEVICE
Lead Sponsor
Tanta University
NCT06593756
NCT06865378
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions